Bio-Techne (TECH) EBIT (2016 - 2025)
Historic EBIT for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $54.5 million.
- Bio-Techne's EBIT rose 1485.06% to $54.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $117.0 million, marking a year-over-year decrease of 4158.28%. This contributed to the annual value of $102.3 million for FY2025, which is 5052.64% down from last year.
- According to the latest figures from Q4 2025, Bio-Techne's EBIT is $54.5 million, which was up 1485.06% from $47.7 million recorded in Q3 2025.
- Bio-Techne's 5-year EBIT high stood at $94.5 million for Q2 2023, and its period low was -$23.9 million during Q2 2025.
- Moreover, its 5-year median value for EBIT was $59.3 million (2021), whereas its average is $57.2 million.
- As far as peak fluctuations go, Bio-Techne's EBIT soared by 7446.45% in 2021, and later plummeted by 15206.99% in 2025.
- Bio-Techne's EBIT (Quarter) stood at $62.3 million in 2021, then increased by 8.89% to $67.9 million in 2022, then plummeted by 44.02% to $38.0 million in 2023, then grew by 24.77% to $47.4 million in 2024, then rose by 14.85% to $54.5 million in 2025.
- Its last three reported values are $54.5 million in Q4 2025, $47.7 million for Q3 2025, and -$23.9 million during Q2 2025.